Prevalence and incidence of multiple sclerosis in Panama (2000-2005)

Neuroepidemiology

Volumn 32, Issue 4, 2009, Pages 287-293

  Gracia, F ^a,f   Castillo, L C ^b   Benzadon A ^b   Larreategui, M ^c   Villareal, F ^b   Triana, E ^b   Arango, A C ^d   Lee, D ^a   Pascale, J M ^e   Gomez, E ^b   Armien, B ^e  

^a Santo Tomas Hospital   (Panama)

^b Caja de Seguro Social   (Panama)

^c Ministerio de Salud   (Panama)

^d Centro Médico Royal Center Paitilla   (Panama)

^e Instituto Conmemorativo Gorgas de Estudios de la Salud   (Panama)

^f Hospital Santo Tomas   (Panama)

Author keywords

Multiple sclerosis, prevalence and incidence; Panama

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBELLOUS SYNDROME; CEREBELLUM DISEASE; CLINICAL FEATURE; DIAGNOSTIC TEST; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MCDONALD CRITERIA; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PANAMA; POSER CRITERIA; PREVALENCE; SCORING SYSTEM; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOVEMENT DISORDERS; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPSYCHOLOGICAL TESTS; OPTIC NEURITIS; PANAMA; PREVALENCE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; YOUNG ADULT;

EID: 60749110958     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000204912     Document Type: Article

References (36)

1. Rivera VM: Perspectives on multiple sclerosis in Latin America: a review. On behalf of the LACTRIMS Steering Committee (2005). CMSC Meet, Washington, May 2007.
2. Corona T, Roman GC: Multiple sclerosis in Latin America. Neuroepidemiology 2006; 26: 1-3.
3. Araujo CR, Moreira MA, Lana-Peixoto MA: Profile of the Brazilian scientific production in multiple sclerosis. Braz J Med Biol Res 2006; 39: 1143-1148.
4. Lana-Peixoto M, Araujo C, Macedo R, Haase VG: Studies on multiple sclerosis: the geographical distribution. Mult Scler 2002; 8: S39.
5. Roman GC, Castellano-Mateus P: Multiple sclerosis; in Feigin VL, Bennett DA (eds): Handbook of Clinical Neuroepidemiology. New York, Nova Science Publishers, 2007, pp 557-572.
6. LACTRIMS, presented at the IV Congress of the Latin American Committee for Treatment and Research in Multiple Sclerosis: Isla Margarita, Venezuela, June 28-July 01, 2006. Rev Neurol 2006; 43: 15-17.
7. Rosati G: The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22: 117-139.
8. Rivera VM, Avila MC: Esclerosis múltiple en Latinoamérica. ¿Son los criterios de Mcdonald realmente aplicables? Rev Mex Neuroci 2007; 8: 49-56.
9. Mateen FJ: International education issues: neurology and poverty. Neurology 2007; 69: 1724-1726.
10. Gracia F, Castillo L, de Lao SL, Archibold CA, Larreategui M, Reeves WC, Levine P: Neurologic diseases associated with the HTLV-1 Virus in Panama. Rev Med Panama 1990; 15: 197-203.
11. Gracia F, Reeves WC, Levine PH, Cuevas M, Castillo L, Chavarria R, Grimaldo V, Triana E, Arosemena JR, Blattner WA: Human Tcell lymphotropic virus type I and neurologic disease in Panama, 1985 and 1986. Arch Neurol 1990; 47: 634-639.
12. Gracia F, Castillo LC, Larreategui M, Roberts B, Cedeno V, Heneine W, Blattner W, Kaplan JE, Levine PH: Relation between human T-lymphotropic virus type I and neurologic diseases in Panama: 1985-1990. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 192-197.
13. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
15. Kurtzke JF: A new scale for evaluating disability in multiple sclerosis. Neurology 1955; 5: 580-583.
16. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
17. Kurtzke JF: The Disability Status Scale for multiple sclerosis: apologia pro DSS sua. Neurology 1989; 39: 291-302.
18. Kurtzke JF: Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993; 6: 382-427.
19. Toro J, Sarmiento OL, Diaz del Castillo A, Satizabal CL, Ramirez JD, Montenegro AC, Gongora MC, Quinones JA, Diaz A, Tobon A: Prevalence of multiple sclerosis in Bogota, Colombia. Neuroepidemiology 2007; 28: 33- 38.
20. Sanchez JL, Aguirre C, Arcos-Burgos OM, Jimenez I, Jimenez M, Leon F, Pareja J, Pradilla G, Uribe B, Uribe CS, Villa A, Volcy M, Palacio LG: Prevalence of multiple sclerosis in Colombia. Rev Neurol 2000; 31: 1101- 1103.
21. Velazquez-Quintana M, Macias-Islas MA, Rivera-Olmos V, Lozano-Zarate J: Multiple sclerosis in Mexico: a multicentre study. Rev Neurol 2003; 36: 1019-1022.
22. Hernandez-Valero E, Cabrera-Gomez JA, Valenzuela C: Clinical features of multiple sclerosis in western Cuba. A comparison with two other regions in the country. Rev Neurol 2004; 38: 818-823.
23. Rosati G: Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview. Ann Neurol 1994; 36(suppl 2): S164-S174.
24. Pugliatti M, Sotgiu S, Rosati G: The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002; 104: 182-191.
25. Callegaro D, de Lolio CA, Radvany J, Tilbery CP, Mendonca RA, Melo AC: Prevalence of multiple sclerosis in the city of Sao Paulo, Brazil, in 1990. Neuroepidemiology 1992; 11: 11-14.
26. Callegaro D, Goldbaum M, Morais L, Tilbery CP, Moreira MA, Gabbai AA, Scaff M: The prevalence of multiple sclerosis in the city of Sao Paulo, Brazil, 1997. Acta Neurol Scand 2001; 104: 208-213.
27. Barahona J, Montero A, Flores A: Multiple sclerosis in Chile. Arq Neuropsiquiatr 2004; 62: 11.
28. Sánchez LP, Fiol M, Cedó P: Multiple sclerosis in Puerto Rico (experience at the University Hospital). 1. Review of a series of cases. Bol Asoc Med P R 1972; 64: 176-178.
29. Cristiano E, Patrucco L, Garcea O, Carra A, Cáceres F, Krementchutsky M, et al: Prevalence of multiple sclerosis (MS) in Argentina using the capture-recapture method. Neurology 1999; 2(suppl):A438.
30. Ketzoian C, Oeninger C, Alcántaran J, et al: Estudio de la prevalencia de la esclerosis múltiple en Uruguay. Acta Neurol Col 1999; 15: 6.
31. Piedrabuena R, Giobellina R, Alvarez D, Abatedaga V: High prevalence of multiple sclerosis in the city of Oliva, Cordoba, Argentina. Arq Neuropsiquiatr 2004; 62: 13.
32. Papais-Alvarenga R, Miranda Santos C, Abreu J, Siqueira H, Camargo S, Veiga Almeida A, Oliveira S, Klajnberg M: Esclerose múltipla (EM): Perfíl clínico e evolutivo no municipio do Río de Janeiro. Rev Bras Neurol 1995; 31: 75-87.
33. Papais-Alvarenga R, Miranda Santos C, Colin D, Peixoto E, Camargo S: Esclerose múltipla (EM): Influéncia do sexo e da etnia no perfil clinico de 88 pacientes no municipio do Río de Janeiro. Rev Bras Neurol 1995; 31: 89-98.
34. Vizcarra-Escobar D, Cava-Prado L, Tipismana- Barbaran M: Multiple sclerosis in Peru. A clinical-epidemiological description of a series of patients. Rev Neurol 2005; 41: 591-595.
35. Programa de las Naciones Unidas para el desarrollo. Informe nacional de desarrollo humano, Panamá 2002. El compromiso con el desarrollo humano: Un desafío nacional. 2002, pp 63-99.
36. International Working Group for Disease Monitoring and Forecasting. Capture-recapture and multiple-record systems estimation. 2. Applications in human diseases. Am J Epidemiol 1999; 142: 1059-1068.